-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
Adaptive clinical trials and their potential to improve drug-development efficiency
Christopher J Weir
Opinion Article: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
Topical diltiazem in management of chronic anal fissure: a review of the literature
Roja Hadianamrei
Clinical Trail Outcomes: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
Future outlook of nonpharmacological treatments for insomnia in adults: clinical trial progress
Richard R Bootzin,Rachel Manber
Editorial: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation